Herms, Albert http://orcid.org/0000-0003-2999-8196
Colom, Bartomeu http://orcid.org/0000-0001-6256-6462
Piedrafita, Gabriel http://orcid.org/0000-0001-8701-1084
Kalogeropoulou, Argyro
Banerjee, Ujjwal
King, Charlotte http://orcid.org/0000-0003-2543-1993
Abby, Emilie http://orcid.org/0000-0003-0284-4760
Murai, Kasumi
Caseda, Irene
Fernandez-Antoran, David http://orcid.org/0000-0003-1608-570X
Ong, Swee Hoe http://orcid.org/0000-0002-3629-5387
Hall, Michael W. J. http://orcid.org/0000-0003-2904-6902
Bryant, Christopher
Sood, Roshan K. http://orcid.org/0000-0002-1318-7025
Fowler, Joanna C. http://orcid.org/0000-0001-7546-369X
Pol, Albert
Frezza, Christian http://orcid.org/0000-0002-3293-7397
Vanhaesebroeck, Bart http://orcid.org/0000-0002-7074-3673
Jones, Philip H. http://orcid.org/0000-0002-5904-795X
Funding for this research was provided by:
Cancer Research UK (C609/A27326, C609/A17257, C23338/A25722)
Wellcome Trust (296194, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D, 108413/A/15/D)
European Molecular Biology Organization (EMBO ALTF885-2015)
Maria Zambrano Grant to attract international talent from Universitat de Barcelona and Ministerio de Universidades, cofunded with Next Generation EU funds
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (PID2020-116163GA-I00)
Article History
Received: 3 January 2023
Accepted: 31 July 2024
First Online: 21 August 2024
Competing interests
: B.C. is an employee of Altos Labs (Cambridge, UK). B.V. is a consultant for iOnctura (Geneva, Switzerland), Venthera (Palo Alto, CA, United States), Olema Pharmaceuticals (San Francisco, CA, United States) and Pharming (Leiden, The Netherlands). The other authors declare no competing interests.